Elevated plasma concentrations of lipoprotein(a) in medicated epileptic patients

Journal of Neurology

Volumn 247, Issue 9, 2000, Pages 687-690

  Schwaninger, Markus ^a   Ringleb, Peter ^a   Annecke, Andrea ^a   Winter, Ralph ^a   Kohl, Brigitte ^a   Werle, Egon ^a   Fiehn, Walter ^a   Rieser, Peter A ^b   Walter Sack, Ingeborg ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Heidelberger Druckmaschinen ^*  (Germany)

Author keywords

Antiepileptic drugs; Arteriosclerosis; Carotid intima media thickness; Lipoprotein(a)

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CLOBAZAM; LIPOPROTEIN A; PHENOBARBITAL; PHENYTOIN; VALPROIC ACID; VIGABATRIN;

ADULT; ANALYTIC METHOD; ARTERIOSCLEROSIS; ARTERY INTIMA PROLIFERATION; ARTICLE; B SCAN; CAROTID ARTERY; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CHOICE; EPILEPSY; FEMALE; HUMAN; HYPERLIPOPROTEINEMIA; LIPOPROTEIN BLOOD LEVEL; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR;

ADULT; ANTICONVULSANTS; ARTERIOSCLEROSIS; CAROTID STENOSIS; EPILEPSY; FEMALE; HUMAN; LIPOPROTEIN(A); MALE; MIDDLE AGE; RISK FACTORS; TIME FACTORS;

EID: 0033772392     PISSN: 03405354     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004150070111     Document Type: Article

References (27)

1. Plasma lipoprotein(a) is an independent factor associated with carotid wall thickening in severely but not moderately hypercholestolemic patients
2. D-thyroxine reduces lipoprotein(a) serum concentration in dialysis patients
3. Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger
4. Common carotid intima-media thickness and risk of stroke and myocardial infarction
5. The relation of lipoprotein(a) concentrations and apolipoprotein(a) phenotypes with asymptomatic atherosclerosis in subjects of the Atherosclerosis Risk in Communities (ARIC) study
6. The effect of chronic phenytoin treatment on serum lipid profile in adult epileptic patients
7. The mortality of epilepsy
8. Mortality from epilepsy: Results from a prospective population-based study
9. Effects of long-term treatment with antiepileptic drugs on serum lipid levels in children with epilepsy
10. Total cholesterol, high-density lipoprotein cholesterol, and triglycerides in children receiving antiepileptic drugs
11. Effect of oral estradiol on Lp(a) and other lipoproteins in postmenopausal women
12. Serum lipid levels during carbamazepine medication
13. Changes in Lp(a) lipoprotein and lipid levels after cessation of female sex hormone production and estrogen replacement therapy
14. Vereinfachte lipoproteinanalyse mit der ultrazentrifuge
15. Myocardial infarction in epileptics
16. Increase of lipoprotein(a) with troglitazone
17. Effects of valproate, phenobarbital, and carbamazepine on sex steroid setup in women with epilepsy
18. Mortality from ischaemic heart disease among patients using anticonvulsive drugs: A case-control study
19. Lipoprotein(a) as a determinant of coronary heart disease in young women
20. Lipoprotein and apolipoprotein profile in men with ischemic stroke: Role of lipoprotein(a), triglyceride-rich lipoproteins, and apolipoprotein E polymorphism
21. Ultrasonographically assessed carotid morphology and the risk of coronary heart disease
22. Seizures and epilepsy in the elderly
23. Elevated plasma concentrations of homocysteine in antiepileptic treatment
24. Relation of serum lipoprotein(a) concentration and apolipoprotein(a) phenotype to coronary heart disease in patients with familial hypercholesterolemia
25. Serum lipids in children treated with carbamazepine and valproate
26. Changes in serum lipids and lipoproteins in epileptic children treated with anticonvulsants
27. Anticonvulsant drugs and cancer